- Home
- About
- Find staff
- Ali Mohaghegh Harandi
Ali Mohaghegh Harandi
Researcher
Department of Microbiology and-
Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North
America
Paola Andrea Martinez-Murillo, Angela Huttner, Sylvain Lemeille, Donata Medaglini, Tom H. M. Ottenhoff, Ali M Harandi, Arnaud M. Didierlaurent, Claire-Anne Siegrist
FRONTIERS IN IMMUNOLOGY - 2024 -
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year
durability
Angela Huttner, Selidji Todagbe Agnandji, Olivier Engler, Jay W. Hooper, Steve Kwilas, Keersten Ricks, Tamara L. Clements, Hulda R. Jonsdottir, Sravya Sowdamini Nakka, Sylvia Rothenberger, Peter Kremsner, Roland Zust, Donata Medaglini, Tom Ottenhoff, Ali M Harandi, Claire-Anne Siegrist
CLINICAL MICROBIOLOGY AND INFECTION - 2023 -
Detoxified synthetic bacterial membrane vesicles as a vaccine platform against bacteria and
SARS-CoV-2
Kyong-Su Park, Kristina Svennerholm, Rossella Crescitelli, Cecilia Lässer, Inta Gribonika, Mickael Andersson, Jonas Boström, Hanna Alalam, Ali M Harandi, Anne Farewell, Jan Lötvall
Journal of Nanobiotechnology - 2023 -
Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine
rVSVΔG-ZEBOV-GP
Eleonora Vianello, Josefine Persson, Björn Andersson, Suzanne van Veen, Thomaz Lüscher Dias, Francesco Santoro, Malin Östensson, Ogonna Obudulu, Christopher Agbajogu, Sara Torkzadeh, Selidji Todagbe Agnandji, Rafi Ahmed, Jenna Anderson, Floriane Auderset, Philip Bejon, Luisa Borgianni, Jessica Brosnahan, Annalisa Ciabattini, Olivier Engler, Marielle C. Haks, Ali M Harandi, Donald Gray Heppner, Alice Gerlini, Angela Huttner, Peter G. Kremsner, Donata Medaglini, Thomas Monath, Francis Ndungu, Patricia Njuguna, Tom H.M. Ottenhoff, David Pejoski, Mark Page, Gianni Pozzi, Claire Anne Siegrist, Sheri Dubey, Micheal J. Eichberg, Patrícia Gonzalez-Dias, Paulin Ndong Essone, Lumeka Kabwende, Peter Gottfried Kremsner, Helder Nakaya, Sravya S. Nakka, Mariëlle C. Haks, Sylvia Rothenberger, Helder I. Nakaya
iScience - 2023 -
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple
cohorts
Patrícia Conceição Gonzalez Dias Carvalho, Thiago Dominguez Crespo Hirata, Leandro Yukio Mano Alves, Isabelle Franco Moscardini, Ana Paula Barbosa do Nascimento, André G. Costa-Martins, Sara Sorgi, Ali M Harandi, Daniela M. Ferreira, Eleonora Vianello, Mariëlle C. Haks, Tom H.M. Ottenhoff, Francesco Santoro, Paola Martinez-Murillo, Angela Huttner, Claire Anne Siegrist, Donata Medaglini, Helder I. Nakaya
Frontiers in Immunology - 2023 -
Antibody and B-cell Immune Responses Against Bordetella Pertussis Following Infection and
Immunization
Bahaa Abu-Raya, Mirjam J. Esser, Eve Nakabembe, Jesús Reiné, Kyle Amaral, Annieck M. Diks, Esther Imede, Sing Sing Way, Ali M Harandi, Andrew Gorringe, Kirsty Le Doare, Scott A. Halperin, Magdalena A. Berkowska, Manish Sadarangani
Journal of Molecular Biology - 2023 -
Anti-Toxin Responses to Natural Enterotoxigenic <i>Escherichia coli</i> (ETEC) Infection in Adults and Children in
Bangladesh
P. Girardi, T. R. Bhuiyan, Samuel B Lundin, S. Harutyunyan, I. Neuhauser, F. Khanam, G. Nagy, V. Szijártó, T. Henics, E. Nagy, Ali M Harandi, F. Qadri
Microorganisms - 2023 -
Tape-disc-loop-mediated isothermal amplification (TD-LAMP) method as noninvasive approach for diagnosis of cutaneous leishmaniasis caused by L.
tropica
Y. Taslimi, S. Habibzadeh, V. M. Goyonlo, A. Akbarzadeh, Z. Azarpour, S. Gharibzadeh, M. Shokouhy, Josefine Persson, Ali M Harandi, A. Mizbani, S. Rafati
Heliyon - 2023 -
A novel precision-serology assay for SARS-CoV-2 infection based on linear B-cell epitopes of Spike
protein
Samuel B Lundin, Hanna Kann, A. Fulurija, Björn Andersson, Sravya Sowdamini Nakka, Lars-Magnus Andersson, Magnus Gisslén, Ali M Harandi
Frontiers in Immunology - 2023 -
Transcriptomics unravels molecular changes associated with cilia and COVID-19 in chronic rhinosinusitis with nasal
polyps
Åsa Torinsson Naluai, Malin Östensson, Philippa Fowler, Sanna Abrahamsson, Björn Andersson, Stina Lassesson, Frida Jacobsson, M. Oscarsson, A. Bohman, Ali M Harandi, M. Bende
Scientific Reports - 2023 -
C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in
neonates
M. Vono, B. Mastelic-Gavillet, E. Mohr, Malin Östensson, Josefine Persson, T. A. Olafsdottir, S. Lemeille, D. Pejoski, O. Hartley, D. Christensen, P. Andersen, A. M. Didierlaurent, Ali M Harandi, P. H. Lambert, C. A. Siegrist
FRONTIERS IN IMMUNOLOGY - 2023 -
Stratification of COVID-19 patients based on quantitative immune-related gene expression in whole
blood.
Josefine Persson, Björn Andersson, Suzanne van Veen, Mariëlle C Haks, Ogonna Obudulu, Sara Torkzadeh, Tom H M Ottenhoff, Nelly Kanberg, Magnus Gisslén, Lars-Magnus Andersson, Ali M Harandi
Molecular immunology - 2022 -
Blood transcriptional profiles distinguish different clinical stages of cutaneous leishmaniasis in
humans
F. Bahrami, N. Masoudzadeh, S. Van Veen, Josefine Persson, A. Lari, H. Sarvnaz, Y. Taslimi, Malin Östensson, Björn Andersson, I. Sharifi, V. M. Goyonlo, T. H. Ottenhoff, M. C. Haks, Ali M Harandi, S. Rafati
Molecular Immunology - 2022 -
Impact of the Rotavirus Vaccination Program in Norway After Four Years With High
Coverage
L. M. R. Diaz, Mdjbl Gonzalez, M. Cuello, V. G. Sierra-Gonzalez, R. R. Pupo, M. I. Lantero, Ali M Harandi, S. Black, O. Perez
Pediatric Infectious Disease Journal - 2021 -
Comparable endemic coronavirus nucleoprotein-specific antibodies in mild and severe Covid-19
patients
Susannah Leach, Ali M Harandi, Tomas Bergström, Lars-Magnus Andersson, Staffan Nilsson, L. van der Hoek, Magnus Gisslén
Journal of Medical Virology - 2021 -
Single-cell BCR and transcriptome analysis after influenza infection reveals spatiotemporal dynamics of antigen-specific B
cells.
Nimitha Rose Mathew, Jayalal Jayanthan, Ilya Smirnov, Jonathan L Robinson, Hannes Axelsson, Sravya Sowdamini Nakka, Aikaterini Emmanouilidi , Paulo Czarnewski, William T Yewdell, Karin Schön, Cristina Lebrero-Fernandez, Valentina Bernasconi, William Rodin, Ali M Harandi, Nils Y Lycke, Nicholas Borcherding, Jonathan W Yewdell, Victor Greiff, Mats Bemark, Davide Angeletti
Cell reports - 2021 -
Profiling inflammatory response in lesions of cutaneous leishmaniasis patients using a non-invasive sampling method combined with a high-throughput protein detection
assay
Y. Taslimi, Christopher Agbajogu, S. F. Brynjolfsson, N. Masoudzadeh, V. Mashayekhi, S. Gharibzadeh, Malin Östensson, Sravya Sowdamini Nakka, A. Mizbani, S. Rafati, Ali M Harandi
Cytokine - 2020 -
Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania
tropica.
Nasrin Masoudzadeh, Malin Östensson, Josefine Persson, Vahid Mashayekhi Goyonlo, Christopher Agbajogu, Yasaman Taslimi, Reza Erfanian Salim, Farnaz Zahedifard, Amir Mizbani, Housein Malekafzali Ardekani, Bronwyn M Gunn, Sima Rafati, Ali M Harandi
Scientific reports - 2020 -
Metabolic Profiling and Compound-Class Identification Reveal Alterations in Serum Triglyceride Levels in Mice Immunized with Human Vaccine Adjuvant
Alum.
Sakda Khoomrung, Intawat Nookaew, Partho Sen, Thorunn A Olafsdottir, Josefine Persson, Thomas Moritz, Ali M Harandi, Jens Nielsen
Journal of proteome research - 2020 -
Systems analysis of human vaccine
adjuvants
Ali M Harandi
Seminars in Immunology - 2018 -
Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in
Humans
Jenna Anderson, Torunn Olafsdottir, S. Kratochvil, P. F. McKay, Malin Östensson, Josefine Persson, R. J. Shattock, Ali M Harandi
Frontiers in Immunology - 2018 -
Biomarkers of Cutaneous
Leishmaniasis
F. Bahrami, Ali M Harandi, S. Riafati
Frontiers in Cellular and Infection Microbiology - 2018 -
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and
Africa
A. Huttner, C. Combescure, S. Grillet, M. C. Haks, E. Quinten, C. Modoux, S. T. Agnandji, J. Brosnahan, J. A. Dayer, Ali M Harandi, L. Kaiser, D. Medaglini, T. Monath, P. Roux-Lombard, P. G. Kremsner, T. H. M. Ottenhoff, C. A. Siegrist
Science Translational Medicine - 2017 -
Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine
Adjuvants
Torunn Olafsdottir, Madelene Lindqvist, I. Nookaew, P. Andersen, J. Maertzdorf, Josefine Persson, D. Christensen, Yuan Zhang, Jenna Anderson, Sakda Khoomrung, E. M. Agger, R. Coler, D. Carter, A. Meinke, R. Rappuoli, S. H. E. Kaufmann, S. G. Reed, Ali M Harandi
Scientific Reports - 2016 -
Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2
infection
Emilie Bardel, Remi Doucet-Ladeveze, Cyrille Mathieu, Ali M Harandi, Bertrand Dubois, Dominique Kaiserlian
npj Vaccines - 2016 -
Toxin-Based Mucosal
Adjuvants
Ali M Harandi, Nils Y Lycke
Immunopotentiators in Modern Vaccines (Second Edition) - 2016 -
Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea
Pigs
Josefine Persson, Yuan Zhang, Torunn Olafsdottir, Karolina Thörn, T. M. Cairns, F. Wegmann, Q. J. Sattentau, R. J. Eisenberg, G. H. Cohen, Ali M Harandi
Frontiers in Immunology - 2016 -
Different human vaccine adjuvants promote distinct antigenin-dependent immunological signatures tailored to different
pathogens
N. P. H. Knudsen, A. Olsen, C. Buonsanti, F. Follmann, Yuan Zhang, R. N. Coler, C. B. Fox, A. Meinke, U. D. Oro, D. Casini, A. Bonci, R. Billeskov, E. De Gregorio, R. Rappuoli, Ali M Harandi, P. Andersen, E. M. Agger
Scientific Reports - 2016 -
Ebola vaccine R&D: Filling the knowledge
gaps
D. Medaglini, Ali M Harandi, T. H. M. Ottenhof, C. A. Siegrist
Science Translational Medicine - 2015 -
Molecular signatures of vaccine
adjuvants
Torunn Olafsdottir, Madelene Lindqvist, Ali M Harandi
Vaccine - 2015 -
Plant-Based Vaccines: Novel and Low-Cost Possible Route for Mediterranean Innovative Vaccination
Strategies
A. A. E. Aboul-Ata, A. Vitti, M. Nuzzaci, A. K. El-Attar, G. Piazzolla, C. Tortorella, Ali M Harandi, O. Olson, S. A. Wright, P. Piazzolla
Advances in Virus Research - 2014 -
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein
antigens
F. Wegmann, K. H. Gartlan, Ali M Harandi, S. A. Brinckmann, M. Coccia, W. R. Hillson, W. L. Kok, S. Cole, L. P. Ho, T. Lambe, M. Puthia, C. Svanborg, E. M. Scherer, G. Krashias, A. Williams, J. N. Blattman, P. D. Greenberg, R. A. Flavell, A. E. Moghaddam, N. C. Sheppard, Q. J. Sattentau
Nature Biotechnology - 2012 -
Glycoprotein G of Herpes Simplex Virus 2 as a Novel Vaccine Antigen for Immunity to Genital and Neurological
Disease
Staffan Görander, Ali M Harandi, Madelene Lindqvist, Tomas Bergström, Jan-Åke Liljeqvist
Journal of Virology - 2012 -
Nasal and skin delivery of IC31-adjuvanted recombinant HSV-2 gD protein confers protection against genital
herpes
Ben Wizel, Josefine Persson, Karolina Thörn, Nagy Eszter, Ali M Harandi
Vaccine - 2012 -
Unraveling molecular signatures of immunostimulatory adjuvants in the female genital tract through systems
biology
Madelene Lindqvist, Intawat Nookaew, Ingrid Brinkenberg, Emma Samuelson, Karolina Thörn, Jens B. Nielsen, Ali M Harandi
PLoS ONE - 2011 -
Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in
mice.
Judith Del Campo, Madelene Lindqvist, Maribel Cuello, Malin Bäckström, Osmir Cabrerra, Josefine Persson, Oliver Perez, Ali M Harandi
Vaccine - 2010 -
Mucosal
adjuvants.
Ali M Harandi, Donata Medaglini
Current HIV research - 2010 -
'Help' from an unexpected source: polyclonal Tregs enhance antibody response to mucosal
immunization.
Sukanya Raghavan, Ali M Harandi
Immunology and cell biology - 2010 -
Vaccine adjuvants: a priority for vaccine
research.
Ali M Harandi, Donata Medaglini, Robin J Shattock
Vaccine - 2010 -
Assessment of mucosal immunity to
HIV-1.
Vicky Jespers, Ali M Harandi, Jorma Hinkula, Donata Medaglini, Roger Le Grand, Christiane Stahl-Hennig, Willy Bogers, Raphaelle El Habib, Frank Wegmann, Carol Fraser, Martin Cranage, Robin J Shattock, Anna-Lena Spetz
Expert review of vaccines - 2010 -
Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera
toxin.
Chunmei Cheng, Ilham Bettahi, Maria I Cruz-Fisher, Sukumar Pal, Pooja Jain, Zhenyu Jia, Jan Holmgren, Ali M Harandi, Luis M de la Maza
Vaccine - 2009 -
The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral
infection.
Madelene Lindqvist, Josefine Persson, Karolina Thörn, Ali M Harandi
Journal of immunology (Baltimore, Md. : 1950) - 2009 -
Local cytokine and inflammatory responses to candidate vaginal adjuvants in
mice.
Madelene Lindqvist, Nazanin Navabi, Marianne Jansson, Emma Samuelson, Åsa Sjöling, Charlotte Örndal, Ali M Harandi
Vaccine - 2009 -
Immunologic Adjuvant
Research
Ali M Harandi, Ole F Olesen
2009 -
Vaccine adjuvants: scientific challenges and strategic
initiatives.
Ali M Harandi, Gwyn Davies, Ole F Olesen
Expert review of vaccines - 2009 -
Suppression of HIV replication in vitro by CpG and CpG conjugated to the non toxic B subunit of cholera
toxin.
Salma Nowroozalizadeh, Marianne Jansson, Jenni Adamsson, Marianne Lindblad, Eva-Maria Fenyö, Jan Holmgren, Ali M Harandi
Current HIV research - 2008 -
The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H-Pylori in
mice
J. Nyström-Asklin, Jenni Adamsson, Ali M Harandi
Scandinavian Journal of Immunology - 2008 -
Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in
mice.
Sara Tengvall, Ali M Harandi
Journal of reproductive immunology - 2008 -
Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor
88.
Sara Tengvall, Derek O'Hagan, Ali M Harandi
Antiviral research - 2008 -
Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research
priorities.
Diana Boraschi, Markos Abebe Alemayehu, Abraham Aseffa, Francesca Chiodi, John Chisi, Gianfranco Del Prete, T Mark Doherty, Ibrahim Elhassan, Howard Engers, Ben Gyan, Ali M Harandi, Thomas Kariuki, Fred Kironde, Bourema Kouriba, Jean Langhorne, Tamás Laskay, Donata Medaglini, Ole Olesen, Philip Onyebujoh, Carla Palma, Robert Sauerwein, Elopy Sibanda, Ulrich Steinhoff, Aldo Tagliabue, Andreas Thiel, Mahnaz Vahedi, Marita Troye-Blomberg
PLoS neglected tropical diseases - 2008 -
4th International Workshop in Vaccine Adjuvants and Parasitic Vaccines (adjuvant
2008).
Oliver Pérez, Ali M Harandi
Expert review of vaccines - 2008 -
Mucosal adjuvants based on cholera toxin and Escherichia Coli heat-labile
enterotoxin.
Jan Holmgren, Cecil Czerkinsky, Ali M Harandi, Michael Lebens, Jia-Bin Sun
2006 -
CpG oligodeoxynucleotides and mobilization of innate mucosal immunity: tasks and
tactics.
Ali M Harandi, Jan Holmgren
Vaccine - 2006 -
Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera
toxin.
Jenni Adamsson, Marianne Lindblad, Annika Lundqvist, Denise Kelly, Jan Holmgren, Ali M Harandi
Journal of immunology (Baltimore, Md. : 1950) - 2006 -
Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital
herpes.
Sara Tengvall, Annika Lundqvist, Roselyn J Eisenberg, Gary H Cohen, Ali M Harandi
Journal of virology - 2006 -
Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG
DNA
Jan Holmgren, Jenni Adamsson, F. Anjuere, J. Clemens, C. Czerkinsky, Kristina Eriksson, Carl-Fredrik Flach, Annie George-Chandy, Ali M Harandi, Michael Lebens, T. Lehner, Marianne Lindblad, Erik Nygren, Sukanya Raghavan, Joaquin Sanchez, M. Stanford, Jia-Bin Sun, Ann-Mari Svennerholm, Sara Tengvall
Immunol Lett - 2005 -
Mucosal immunity and vaccine
design.
Cecil Czerkinsky, Ali M Harandi, Jan Holmgren
2005 -
CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in
mice.
Sara Tengvall, Agnetha Josefsson, Jan Holmgren, Ali M Harandi
Journal of reproductive immunology - 2005 -
CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal
infections.
Ali M Harandi, Jan Holmgren
Current opinion in investigational drugs (London, England : 2000) - 2004 -
The potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and
challenges.
Ali M Harandi
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 2004 -
Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori
infection.
Sukanya Raghavan, J Nyström, M Fredriksson, Jan Holmgren, Ali M Harandi
Infection and immunity - 2003 -
Innate and adaptive immunity in genital HSV-2 infection: Implications for vaccine
development
Ali M Harandi
2001